Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B.

Zhan X, Hurwitz JL, Krishnamurthy S, Takimoto T, Boyd K, Scroggs RA, Surman S, Portner A, Slobod KS.

Vaccine. 2007 Dec 17;25(52):8782-93. Epub 2007 Nov 5.

2.

Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus.

Takimoto T, Hurwitz JL, Zhan X, Krishnamurthy S, Prouser C, Brown B, Coleclough C, Boyd K, Scroggs RA, Portner A, Slobod KS.

Viral Immunol. 2005;18(2):255-66. Review.

PMID:
16035938
3.

[Research Progress in the F Gene and Protein of the Respiratory Syncytial Virus].

Zhang F, Xie Z.

Bing Du Xue Bao. 2015 Mar;31(2):201-6. Review. Chinese.

PMID:
26164949
4.

Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses.

Russell CJ, Hurwitz JL.

Expert Rev Vaccines. 2016;15(2):189-200. doi: 10.1586/14760584.2016.1114418. Epub 2015 Dec 9. Review.

5.

New insights for development of a safe and protective RSV vaccine.

Blanco JC, Boukhvalova MS, Shirey KA, Prince GA, Vogel SN.

Hum Vaccin. 2010 Jun;6(6):482-92. Epub 2010 Jun 1. Review.

6.

Strategic priorities for respiratory syncytial virus (RSV) vaccine development.

Anderson LJ, Dormitzer PR, Nokes DJ, Rappuoli R, Roca A, Graham BS.

Vaccine. 2013 Apr 18;31 Suppl 2:B209-15. doi: 10.1016/j.vaccine.2012.11.106. Review.

7.

Carriers for the delivery of a vaccine against respiratory syncytial virus.

Cranage M, Taylor G.

Expert Opin Biol Ther. 2005 Jul;5(7):939-52. Review.

PMID:
16018739
8.

Respiratory syncytial virus vaccine development.

Hurwitz JL.

Expert Rev Vaccines. 2011 Oct;10(10):1415-33. doi: 10.1586/erv.11.120. Review.

9.

Protective and dysregulated T cell immunity in RSV infection.

Openshaw PJ, Chiu C.

Curr Opin Virol. 2013 Aug;3(4):468-74. doi: 10.1016/j.coviro.2013.05.005. Epub 2013 Jun 25. Review.

10.

Recombinant measles AIK-C vaccine strain expressing heterologous virus antigens.

Nakayama T, Sawada A, Yamaji Y, Ito T.

Vaccine. 2016 Jan 4;34(2):292-295. doi: 10.1016/j.vaccine.2015.10.127. Epub 2015 Nov 10. Review.

PMID:
26562316
11.

Respiratory viruses and eosinophils: exploring the connections.

Rosenberg HF, Dyer KD, Domachowske JB.

Antiviral Res. 2009 Jul;83(1):1-9. doi: 10.1016/j.antiviral.2009.04.005. Epub 2009 Apr 16. Review.

12.
13.

Vaccines and cytokine-mediated pathology in RSV infection.

Doherty PC.

Trends Microbiol. 1994 May;2(5):148-9; discussion 149-50. Review. No abstract available.

PMID:
8055177
14.

Protective and Harmful Immunity to RSV Infection.

Openshaw PJM, Chiu C, Culley FJ, Johansson C.

Annu Rev Immunol. 2017 Apr 26;35:501-532. doi: 10.1146/annurev-immunol-051116-052206. Epub 2017 Feb 6. Review.

PMID:
28226227
15.

Controlled human infection with RSV: The opportunities of experimental challenge.

Habibi MS, Chiu C.

Vaccine. 2017 Jan 11;35(3):489-495. doi: 10.1016/j.vaccine.2016.08.086. Epub 2016 Nov 23. Review.

PMID:
27889256
16.

RSV fusion: time for a new model.

Mastrangelo P, Hegele RG.

Viruses. 2013 Mar 19;5(3):873-85. doi: 10.3390/v5030873. Review.

17.
18.

[Potential neurocognitive consequences of infection by human respiratory syncytial virus].

Flores JC, Bohmwald K, Espinoza J, Jara C, Peña M, Hoyos-Bachiloglu R, Iturriaga C, Kalergis AM, Borzutzky A.

Rev Chilena Infectol. 2016 Oct;33(5):537-542. doi: 10.4067/S0716-10182016000500008. Review. Spanish.

19.

Strategies to develop vaccines of pediatric interest.

Esposito S, Principi N European Society Of Clinical Microbiology And Infectious Diseases Escmid Vaccine Study Group Evasg.

Expert Rev Vaccines. 2017 Feb;16(2):175-186. doi: 10.1080/14760584.2017.1237875. Epub 2016 Sep 28. Review.

PMID:
27653455
20.

Parainfluenza virus 5-vectored vaccines against human and animal infectious diseases.

Chen Z.

Rev Med Virol. 2018 Jan 5. doi: 10.1002/rmv.1965. [Epub ahead of print] Review.

PMID:
29316047

Supplemental Content

Support Center